Compare Charles River Laboratories Intl. Inc (CRL) vs EPR Properties (EPR) Price & Performance

Charles River Laboratories (CRL) trades at $298, down 0.77% on the day, with strong analyst support showing 73% buy ratings and a $305.50 consensus price target. The stock maintains a bullish technical outlook with support at $292 and resistance at $301, while recent earnings have consistently beaten expectations despite negative net income margins. The company's 2026 Investor Day highlighted a strategic vision targeting 5-7% organic growth and $300 million in savings by 2030.

CRL presents a compelling growth story with solid operational cash flow and strategic initiatives, though investors face risks from negative profitability metrics and elevated valuation multiples. The stock's current position near analyst targets suggests limited upside without improved earnings execution, while ongoing margin pressures and debt levels require careful monitoring amid the company's transformation efforts.

EPR Properties trades at $54.41, up 0.61% today, with a bearish technical signal but oversold oscillators suggesting potential reversal. The REIT reported strong profitability with a 37.66% net income margin and a 6.5% dividend yield, though Q1 2026 earnings missed expectations. Recent news highlights its appeal for income investors, with monthly dividends and diversification into theme parks and fitness.

Outlook is mixed: analyst consensus is a Buy with a $65.50 target, but technicals and a projected 2026 net income decline pose risks. The stock offers value at a P/E of 17.44 and high yield, yet investors face headwinds from rising Treasury yields and competitive pressures in the net lease REIT sector.